The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group
(Q28373805)
scientific article
scientific article
Language:
Current Data About
The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
487-97
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
4
|
||||||||||||||||
| (P478) |
15
|
||||||||||||||||
| (P577) |
+2000-04-00T00:00:00Z
|
||||||||||||||||
| (P921) |
(Q1145523)
(Q1129105)
|
||||||||||||||||
| (P1433) |
(Q15710302)
|
||||||||||||||||
| (P1476) |
"The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" (language: en)
|
||||||||||||||||
| (P2093) |
R A Rodby
R D Rohde
W R Clarke
L G Hunsicker
D A Anzalone
R C Atkins
E Ritz
E J Lewis
|
other details